Primary Care Companion E-lert


The Primary Care Companion for
CNS Disorders

Register | Current Issue | Information for Authors | About E-Lerts | CNS for Primary Care Publisher's Podcast

The Effect of Armodafinil on Patient-Reported Functioning and Quality of Life in Patients With Excessive Sleepiness Associated With Shift Work Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Milton K. Erman, MD; Ronghua Yang, PhD; and David J. Seiden, MD

Up to 45% of night shift workers report excessive sleepiness and are more likely to develop shift work disorder. This study examined whether 6 weeks of the wakefulness-promoting agent armodafinil could improve overall functioning and daily quality of life versus placebo in patients with excessive sleepiness associated with shift work disorder.

[Abstract] [Full Text]

For more free peer-reviewed articles, visit the Companion at If you are having trouble reading this E-Lert, see

Like us on Facebook
Follow us on Twitter

You are receiving this update as a benefit of your membership.

To ensure delivery of these messages add to your address book. If you would not like to receive further E-Lerts, go to and click the "Unsubscribe from E-Lerts" link. If you are having trouble unsubscribing, contact the web administrator for assistance.

If you are having trouble with your membership, contact our circulation department. Direct any other questions or comments to the web administrator.

Physicians Postgraduate Press, Inc. | 850 Ridge Lake Boulevard, Suite 300 | Memphis, TN 38120

Please do not reply directly to this e-mail. Neither nor any of its family of websites will ask you to send us profile information via e-mail.

If you cannot read this, go to

© Copyright 2012, Physicians Postgraduate Press, Inc. All rights reserved.